Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase 1 Clinical Trial Abstract Liver safety concerns were raised in randomized controlled trials of cannabidiol (CBD) in patients with Lennox‐Gastaut and Dravet syndromes but the relevance of these concerns to healthy adults consuming CBD is unclear. The objective of this manuscript is to […]
CBD Concerns Continue to Emerge Read More »
In a post Covid world where economists and politicians are warning of Depression era levels of financial downturn the dire consequences of marijuana legalisation are for those that can least afford it. With more data showing THC levels (chemicals causing the ‘high’ in cannabis) more powerful than decades earlier and a host of dangerous chemicals
Colorado – A Post Legalisation Summary Read More »
Lessons Learned from Marijuana Legalisation 2020 Report (SAM) KEY OUTCOMES: Like with our past in tobacco, the full consequences of marijuana commercialization will materialize over decades. However, we do not need to wait that long to understand some key outcomes. For example, the data in this report—and many others—show states that legalized marijuana have among
Are We Learning? Marijuana Legalisation – 2020 Report Read More »
Prenatal cannabis exposure associated with adverse outcomes during middle childhood The findings are reported as use of cannabis during pregnancy has ‘skyrocketed’ Date: September 23, 2020 Source: Washington University in St. Louis While cannabis use during pregnancy is on the rise, researchers at Washington University in St. Louis have found evidence that the resulting children
Cannabis Use During Pregnancy is a Serious Issue for Child Development Read More »
Over-the-counter medicinal cannabis plan not what it seems, experts warn September 14, 2020 (Sydney Morning Herald) Medicinal cannabis could be available over-the-counter in Australia by next year as the national medicines regulator weighs a proposal to allow it to be sold without a prescription, but some experts warn the approach could backfire. New research published
Over-the-Counter CBD. Proper Research, Caution & Regulation Needed Read More »
Informing the Public or the Public informing? In April 2019 headlines trumpeted that, Medicinal cannabis supply to reach new high with first-ever pot factory in NSW, so goes all such cannabis focused by lines these days, unhelpfully painting cannabis in a ‘health’ light. Of course, click bait phrases are engaged for further reading. However, it
Media Release: 25th August 2020 BREAKING: Marijuana Workforce Positivity Rates Skyrocketing in Legal States (Alexandria, VA) – Today, national data released by Quest Diagnostics found that rates of marijuana positivity in the workforce have sharply risen both over the last year (2018-2019) and since legalization was implemented. Furthermore, Quest Diagnostics also reported that workforce drug
Weed and Workforce – a REAL Worry! Read More »
Cannabinoids, including CBD, may interact with prescribed drugs Researchers have published a list of 57 medications that may interact with cannabinoid products, including cannabis and cannabidiol (CBD) oil. The list includes commonly prescribed medications, such as anticoagulants, pain relievers, and birth control pills. The list displays a range of medicines, including antidepressants (such as amitriptyline,
More Warnings on CBD! Read More »
What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding FDA strongly advises against the use of cannabidiol (CBD), tetrahydrocannabinol (THC), and marijuana in any form during pregnancy or while breastfeeding. What do we know about the effects of marijuana use during pregnancy and while breastfeeding? There are many potential negative health
F.D.A. Release Another Warning Over Cannabis Use – of Any Type – During Pregnancy Read More »
